IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 127 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,188 | -35.4% | 1,360,000 | 0.0% | 0.08% | -31.5% |
| Q2 2023 | $9,574 | +15.2% | 1,360,000 | 0.0% | 0.12% | +8.8% |
| Q1 2023 | $8,310 | -4.4% | 1,360,000 | 0.0% | 0.11% | -0.9% |
| Q4 2022 | $8,690 | -99.9% | 1,360,000 | +17.2% | 0.12% | -24.8% |
| Q3 2022 | $11,113,000 | -13.2% | 1,160,000 | 0.0% | 0.15% | -5.0% |
| Q2 2022 | $12,806,000 | +494.0% | 1,160,000 | +411.7% | 0.16% | +496.3% |
| Q1 2019 | $2,156,000 | +7.5% | 226,681 | 0.0% | 0.03% | -6.9% |
| Q4 2018 | $2,006,000 | -55.5% | 226,681 | -43.4% | 0.03% | -50.0% |
| Q3 2018 | $4,507,000 | -8.7% | 400,603 | +3.9% | 0.06% | -14.7% |
| Q2 2018 | $4,934,000 | – | 385,446 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
| Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
| Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
| Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
| Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
| Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
| Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
| Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
| Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
| Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |